These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 3563966

  • 21. Antithrombin III Nagasaki (Ser116-Pro): a heterozygous variant with defective heparin binding associated with thrombosis.
    Okajima K, Abe H, Maeda S, Motomura M, Tsujihata M, Nagataki S, Okabe H, Takatsuki K.
    Blood; 1993 Mar 01; 81(5):1300-5. PubMed ID: 8443391
    [Abstract] [Full Text] [Related]

  • 22. Abnormal properties and behaviors of antithrombin III found in a thrombophilic patient: defective biological functions and dissimilar antigenic determinants.
    Murayama H, Matsuda M.
    Thromb Haemost; 1986 Oct 21; 56(2):165-71. PubMed ID: 3101219
    [Abstract] [Full Text] [Related]

  • 23. Reactivity of a hereditary abnormal antithrombin III fraction in the inhibition of thrombin and factor Xa.
    Tran TH, Bondeli C, Marbet GA, Duckert F.
    Thromb Haemost; 1980 Oct 31; 44(2):92-5. PubMed ID: 7455997
    [Abstract] [Full Text] [Related]

  • 24. Familial variant of antithrombin III (AT III Bligny, 47Arg to His) associated with protein C deficiency.
    Wolf M, Boyer-Neumann C, Molho-Sabatier P, Neumann C, Meyer D, Larrieu MJ.
    Thromb Haemost; 1990 Apr 12; 63(2):215-9. PubMed ID: 2363123
    [Abstract] [Full Text] [Related]

  • 25. Antithrombin III, the major modulator of intravascular coagulation, is synthesized by human endothelial cells.
    Chan TK, Chan V.
    Thromb Haemost; 1981 Aug 28; 46(2):504-6. PubMed ID: 7302889
    [Abstract] [Full Text] [Related]

  • 26. Antithrombin "Chicago": a functionally abnormal molecule with increased heparin affinity causing familial thrombophilia.
    Bauer KA, Ashenhurst JB, Chediak J, Rosenberg RD.
    Blood; 1983 Dec 28; 62(6):1242-50. PubMed ID: 6640109
    [Abstract] [Full Text] [Related]

  • 27. Further investigations on antithrombin III in the plasmas of patients with the abnormality of antithrombin III Budapest.
    Sas G, Pepper DS, Cash JD.
    Thromb Diath Haemorrh; 1975 Jun 30; 33(3):564-72. PubMed ID: 1154312
    [Abstract] [Full Text] [Related]

  • 28. Antithrombin III Pescara: a defective AT III variant with no alterations of plasma crossed immunoelectrophoresis, but with an abnormal crossed immunoelectrofocusing pattern.
    Leone G, De Stefano V, Di Donfrancesco A, Ferrelli R, Traisci G, Bizzi B.
    Br J Haematol; 1987 Feb 30; 65(2):187-91. PubMed ID: 3828226
    [Abstract] [Full Text] [Related]

  • 29. Antithrombin Glasgow, 393 Arg to His: a P1 reactive site variant with increased heparin affinity but no thrombin inhibitory activity.
    Owen MC, Beresford CH, Carrell RW.
    FEBS Lett; 1988 Apr 25; 231(2):317-20. PubMed ID: 3360140
    [Abstract] [Full Text] [Related]

  • 30. An abnormal antithrombin III (AT III) with low heparin affinity: AT III Clichy.
    Aiach M, François D, Priollet P, Capron L, Roncato M, Alhenc-Gelas M, Fiessinger JN.
    Br J Haematol; 1987 Aug 25; 66(4):515-22. PubMed ID: 3663508
    [Abstract] [Full Text] [Related]

  • 31. On the mechanism of coagulation inhibition on surfaces with end point immobilized heparin.
    Elgue G, Blombäck M, Olsson P, Riesenfeld J.
    Thromb Haemost; 1993 Aug 02; 70(2):289-93. PubMed ID: 8236137
    [Abstract] [Full Text] [Related]

  • 32. Effect of individual carbohydrate chains of recombinant antithrombin on heparin affinity and on the generation of glycoforms differing in heparin affinity.
    Olson ST, Frances-Chmura AM, Swanson R, Björk I, Zettlmeissl G.
    Arch Biochem Biophys; 1997 May 15; 341(2):212-21. PubMed ID: 9169007
    [Abstract] [Full Text] [Related]

  • 33. Antithrombin Nagasaki (Ser 116 to Pro): a rare antithrombin variant with abnormal heparin binding presenting during pregnancy.
    O'Ddonnell JS, Hinkson L, McCarthy A, Manning R, Khan A, Laffan MA.
    Blood Coagul Fibrinolysis; 2006 Apr 15; 17(3):217-20. PubMed ID: 16575261
    [Abstract] [Full Text] [Related]

  • 34. Permeability of a heparin-polyvinyl alcohol hydrogel to thrombin and antithrombin III.
    Smith BA, Sefton MV.
    J Biomed Mater Res; 1988 Aug 15; 22(8):673-85. PubMed ID: 3215905
    [Abstract] [Full Text] [Related]

  • 35. Heterogeneity of the "classical" antithrombin III deficiency.
    Sas G, Petö I, Bánhegyi D, Blaskó G, Domján G.
    Thromb Haemost; 1980 Jun 18; 43(2):133-6. PubMed ID: 7455972
    [Abstract] [Full Text] [Related]

  • 36. Conformational conversion of antithrombin to a fully activated substrate of factor Xa without need for heparin.
    Huntington JA, Gettins PG.
    Biochemistry; 1998 Mar 10; 37(10):3272-7. PubMed ID: 9521646
    [Abstract] [Full Text] [Related]

  • 37. Clinical and biochemical characterization of antithrombin III Franconville, a variant with Pro 41 Leu mutation.
    de Roux N, Chadeuf G, Molho-Sabatier P, Plouin PF, Aiach M.
    Br J Haematol; 1990 Jun 10; 75(2):222-7. PubMed ID: 2372510
    [Abstract] [Full Text] [Related]

  • 38. Antithrombin Milano: a new variant with monomeric and dimeric inactive antithrombin III.
    Wolf M, Boyer C, Tripodi A, Meyer D, Larrieu MJ, Mannucci PM.
    Blood; 1985 Feb 10; 65(2):496-500. PubMed ID: 3967090
    [Abstract] [Full Text] [Related]

  • 39. Fate of thrombin and thrombin-antithrombin-III complex adsorbed to a heparinized biomaterial: analysis of the enzyme-inhibitor complexes displaced by plasma.
    Hatton MW, Rollason G, Sefton MV.
    Thromb Haemost; 1983 Dec 30; 50(4):873-7. PubMed ID: 6198746
    [Abstract] [Full Text] [Related]

  • 40. Antithrombin III deficiency.
    Cucuianu M, Blaga S, Pop S, Olinic D, Olinic N, Colhon D, Cristea A.
    Rom J Intern Med; 1994 Dec 30; 32(2):119-27. PubMed ID: 7920326
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.